300 North Capital’s Protolabs PRLB Stock Holding History

300 North Capital’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-33,647	Closed	-$2.28M	–	113
2014 Q1	$2.28M	Buy	33,647 +1,827	+6%	+$136K	0.59%	72
2013 Q4	$2.27M	Buy	31,820 +3,690	+13%	+$286K	0.63%	68
2013 Q3	$2.15M	Buy	28,130 +700	+3%	+$48.5K	0.5%	79
2013 Q2	$1.78M	Buy	+27,430	New	+$1.47M	0.69%	62

Other funds holding PRLB

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

300 North Capital's PRLB Position: Q2 2014 in Review

300 North Capital sold out of Protolabs (PRLB) in Q2 2014, closing a stake of 33,647 shares — an estimated $2.28M sold.

300 North Capital first reported a position in PRLB in Q2 2013 and held it in 4 quarters. The position peaked at $2.28M in Q1 2014. 178 funds tracked by Wall St. Rank hold PRLB as of Q2 2014.

300 North Capital reported no remaining Protolabs position as of Q2 2014 after selling out during the quarter.
300 North Capital sold 33,647 Protolabs shares in Q2 2014, an estimated $2.28M.
300 North Capital first reported a position in Protolabs in Q2 2013 and held it in 4 quarters.
300 North Capital's Protolabs position peaked at $2.28M in Q1 2014.
178 funds tracked by Wall St. Rank held Protolabs as of Q2 2014.

Based on 300 North Capital's 13F filing for Q2 2014, filed 5 Aug 2014.